[Source: Reuters]

China’s introduction of the world’s strictest nutrient standards for infant formula are likely to see scores of brands give up on a market that is shrinking along with the country’s falling birth rates, industry executives and analysts say.

New rules imposed in February force infant formula makers to invest heavily to re-make, test, certify and re-register their products for China, before potentially conducting new marketing campaigns.

This will further shake up an industry already at the forefront of China’s demographic decline, with bigger domestic and international brands likely to increase their market share as smaller ones exit, analysts said.

“The new standard requires higher product quality as well as stronger manufacturing techniques which are expected to eliminate many small-to-medium-size players,” said Quinn Mai, analyst at Euromonitor International, which estimates China’s infant formula market will fall 12.5% to $21 billion by 2025 due to shrinking demand.

China’s new requirements revise the minimum and maximum values of nutrients such as selenium, manganese and choline, mandate lactose content and ban fructose and sucrose.

Many experts describe the regulations as the world’s toughest, aiming to get as close as possible to breast milk.

In 2008, at least six infants died and more than 300,000 fell ill from Chinese formulas tainted with melamine, a toxic chemical used to boost milk protein scores in tests. More than 20 Chinese firms were implicated, one of a series of food safety scandals in the early 2000s which industry executives say still weigh on consumer trust.

China’s National Health Commission (NHC) cited infant safety when announcing the latest rules. NHC and the State Administration for Market Regulation (SAMR) did not immediately respond to comment requests.

“The government needs to show Chinese people that ‘we care about babies, we care about food safety so much that we come up with the strictest formula regulations’,” said Auckland-based Jane Li, who has been involved in the China infant formula market for more than a decade and acts as principal consultant for Li, Page & Co.

“Beijing is very clear in their goal. They want to see fewer and fewer players in the market.”

Chinese regulators have approved submissions by 200 brands, according to analysts and industry executives who expect only a few dozen more to be authorised in coming months.

Under the previous standards, more than 400 brands battled for share in a market where only around 28% of mothers opt to breastfeed versus more than 50% in India and 75% in the U.S., according to Unicef data.

Celia Ning, director at the nutrition research institute of formula maker Junlebao, said the registration process could “easily” take a year. Companies cannot sell new stock until they are approved and if they fail to register their new products early they are “out of the market.”

The process requires many “resources from designing a new formulation, to trial, analysis and registration as well as good documentation and factory inspection.”

She said smaller brands may be put off by extra costs, especially when the whole industry was in a “critical situation” due to an ageing population.

China’s birth rate last year was just 6.77 births per 1,000 people, its lowest on record, and U.N. experts forecast China’s population to shrink by 109 million by 2050.

“Maybe we can increase our market share, but everyone will see total sales reduced,” said Ning, whose company is targeting other milk products such as yoghurt for future growth.